-

Renovus Capital Partners Appoints Niklas Kuhlmann as Director of Investor Relations and Capital Formation, EMEA

PHILADELPHIA & FRANKFURT, Germany--(BUSINESS WIRE)--Renovus Capital Partners (“Renovus”), a Philadelphia-area based investment firm, today announced that Niklas Kuhlmann has joined the firm as Director of Investor Relations and Capital Formation, EMEA.

In this role, Mr. Kuhlmann will lead Renovus’ investor relations and capital formation efforts across Europe and Asia supporting the firm’s deepening relationships with institutional investors in the international markets.

Mr. Kuhlmann brings more than a decade of experience in private markets fundraising and institutional sales. Prior to joining Renovus, he held senior fundraising and business development roles at Selinus Capital, Hamilton Lane, and DWS Group, where he worked extensively with pension funds, family offices, insurance companies, banks, endowments, and consultants across the DACH region and broader Europe.

“Niklas’ appointment reflects the continued momentum of our platform and the growing interest we see from global institutions,” said Atif Gilani, Founding Partner at Renovus Capital Partners. “His experience and relationships will be instrumental as we broaden Renovus’ presence across Europe and Asia and continue to scale our capital base.”

“Renovus is at an exciting inflection point,” said Mr. Kuhlmann. “The firm’s focus on U.S. small-cap buyouts, combined with its operationally driven value creation approach and strong investor outcomes, resonates deeply with international investors seeking long-term, multi-fund partnerships with best-in-class general partners.”

Mr. Kuhlmann holds an MSc in Corporate Finance & Banking from EDHEC Business School and a BSc in International Business from Maastricht University. He is a CAIA charterholder and is based in Frankfurt, Germany.

About Renovus Capital Partners

Founded in 2010, Renovus Capital Partners is a lower middle-market private equity firm specializing in the Knowledge and Talent industries. From its base in the Philadelphia area, Renovus manages over $2 billion of assets across its several sector-focused funds. The firm's current portfolio includes over 30 U.S.-based businesses specializing in education and workforce development and services companies in the technology, healthcare, and professional services markets. Renovus typically makes control buyout investments in founder-owned businesses, leveraging its industry expertise and operator network to make operational improvements, recruit top talent and pursue add-on acquisitions. Visit us at www.renovuscapital.com and follow us on LinkedIn.

Contacts

Media Contact:
Mark Semer/Alex Jeffrey
Gasthalter & Co.
212-257-4170
Renovus@gasthalter.com

Renovus Capital Partners


Release Versions

Contacts

Media Contact:
Mark Semer/Alex Jeffrey
Gasthalter & Co.
212-257-4170
Renovus@gasthalter.com

More News From Renovus Capital Partners

Superior Health Holdings Expands Louisiana Hospice Footprint with Acquisition of Pulse Home Health and Hospice

BATON ROUGE, La.--(BUSINESS WIRE)--Superior Health Holdings (“Superior”), a leading provider of home health and hospice services across Louisiana, today announced the acquisition of the Pulse Home Health and Hospice (“Pulse”), a community-based provider delivering compassionate, high-quality care to patients and families in Louisiana. This acquisition expands Superior’s integrated care capabilities and strengthens its footprint in the Northshore region. Pulse provides a comprehensive continuum...

BlueRidge Life Sciences Acquires Design Science to Expand Human Factors and Usability Engineering Capabilities

KATY, Texas--(BUSINESS WIRE)--BlueRidge Life Sciences (“BlueRidge”), a leading life sciences consulting and services platform and a portfolio company of Renovus Capital Partners, today announced the acquisition of Design Science, a premier human factors and usability engineering consultancy serving medical device, pharmaceutical, and biotechnology companies worldwide. Founded in 1991, Design Science is recognized for its deep expertise in human factors engineering, usability testing, and use-re...

Renovus Capital Partners Announces Sale of Pillr Health

WAYNE, Pa.--(BUSINESS WIRE)--Renovus Capital Partners (“Renovus”), a private equity firm focused on investing in growth-oriented businesses in the Knowledge and Talent industries, today announced the sale of its portfolio company Pillr Health, a technology-enabled pharmacy optimization platform serving healthcare providers nationwide, to Water Street Healthcare Partners. Renovus first partnered with the business in 2019, supporting its evolution from a legacy 340B third-party administrator into...
Back to Newsroom